Clinical Trials Directory

Trials / Sponsors / Palatin Technologies, Inc

Palatin Technologies, Inc

Industry · 11 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingA Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesit
Obesity
Phase 22024-08-05
CompletedA Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease
Kidney Disease
Phase 22022-12-26
Active Not RecruitingPhase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)
Ulcerative Colitis, Ulcerative Colitis Acute, Ulcerative
Phase 22022-09-15
CompletedA Phase 3, Multi-Center Study Evaluating PL9643 in Patients with Dry Eye
Dry Eye, Dry Eye Syndromes
Phase 32021-12-30
TerminatedStudy to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure Subjects
Heart Failure With Preserved Ejection Fraction
Phase 22020-11-12
Completed2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire
Hypoactive Sexual Desire Disorder
Phase 32015-01-01
Completed1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire
Hypoactive Sexual Desire Disorder
Phase 32014-12-01
CompletedBremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disor
Female Sexual Arousal Disorder, Hypoactive Sexual Desire Disorder
Phase 22011-06-01
CompletedSafety Study of Subcutaneously Administered PL-3994 in Subjects With Controlled Hypertension
Hypertension
Phase 22008-04-01
CompletedEvaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)
Sexual Arousal Disorder
Phase 22006-02-01
WithdrawnCross-Over Study of Subcutaneous Study Drug for the Treatment of Patients With Mild to Moderate Asthma
Asthma
Phase 2—